Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

Total article views   Abstract views HTML views PDF downloads Totals
10,491 Dovepress* 8,870 635+ 2,008 9,505
PubMed Central* 4 982 451 986
Totals 8,874 1,617 2,459 10,491
*Since 23 August 2012
+Since July 2016

View citations on PubMed Central and Google Scholar